Centessa Reverses Lower Despite $5 Billion Narcolepsy Opportunity
Centessa Reverses Lower Despite $5 Billion Narcolepsy Opportunity · Investor's Business Daily

In This Article:

Centessa has a potential blockbuster narcolepsy treatment on its hands, an analyst said Tuesday. But the biotech stock reversed into the red.